Remove 2023 Remove Controlled Substances Remove Labelling
article thumbnail

DEA Regs Bulk Up with 2014 Anabolic Steroid Control Law Additions

FDA Law Blog: Biosimilars

Houck — Anabolic steroids that include testosterone, methyltestosterone, nandrolone decanoate and oxandrolone are schedule III controlled substances with currently accepted medical uses in the U.S. Implementation of the Designer Anabolic Steroid Control Act of 2014 , 88 Fed. By Larry K. 50,036 (Aug.

article thumbnail

Joint Basis for FDA/HHS Marijuana Rescheduling Recommendation Unveiled

FDA Law Blog: Biosimilars

Houck — In August 2023 the Food and Drug Administration (“FDA”) and Health and Human Services (“HHS”) recommended that the Drug Enforcement Administration (“DEA”) reschedule marijuana from schedule I under the federal Controlled Substances Act (“CSA”) to schedule III. By Larry K.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

FDA $7bn plans for 2024: disclose contract manufacturers, restart Cancer Moonshot

Pharmaceutical Technology

The FDA’s proposed FY2024 Budget tops $7bn, to be shared between drug, food, and cosmetics tasks and overheads such as buildings; this is $372m higher than in FY 2023, a 10% increase. At present, the FDA can only force recalls for controlled substances and biologics, and relies on voluntary recalls by pharma companies for other drugs.

article thumbnail

FDA Seeks $7.2 Billion to Protect and Advance Public Health

LifeProNow

March 09, 2023: “The U.S. The request includes an increase of $372 million in budget authority — or 10% above the FY 2023 Enacted Level — and a $150 million increase in user fees. 1, 2023, through Sept. Food and Drug Administration announced it is requesting $7.2 The FY 2024 request, which covers the period from Oct.

Labelling 130
article thumbnail

OPDP Comes out Swinging With A Warning Letter on Unsubstantiated Efficacy

FDA Law Blog: Biosimilars

And before CooperSurgical, another 2021 Warning Letter was issued to AcelRx for the infamous “Tongue and Done” tagline used to promote a Schedule II controlled substance subject to a REMS program that requires a healthcare professional’s precise placement of the drug using a single-dose applicator into the patient’s sublingual space.

article thumbnail

Using My Medical Advocate Skills To Detect And Eliminate Errors With My Girlfriend’s Prescription

The Happy PharmD

Dexamethasone oral solution is not a narcotic or controlled substance. In February 2023 she had her next to last refill of the prescription filled. At the beginning of March 2023, I stopped by the pharmacy and asked for the last refill of the Dexamethasone oral solution. This one baffled me.

Dosage 52
article thumbnail

Buckle Up: DOJ Initiates Rulemaking to Reschedule Marijuana

FDA Law Blog: Biosimilars

Houck — Last August Health and Human Services (“HHS”) recommended rescheduling marijuana from schedule I under the federal Controlled Substances Act (“CSA”) to schedule III. Schedules of Controlled Substances: Rescheduling of Marijuana, 89 Fed. 29, 2023) (“Basis”); NPRM at 44,603. By Larry K.